In conclusion, the present study reported for the first time that oral administration of resveratrol as a monotherapy provides a remarkable improvement in clinical status in patients with knee osteoarthritis but has no significant effect on Coll 2-1 and aggrecan turnover. This evidence concerns the gene ACAN and osteoarthritis, knee.